Cargando…
P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429685/ http://dx.doi.org/10.1097/01.HS9.0000847332.17703.45 |
| _version_ | 1784779535462432768 |
|---|---|
| author | Carlostella, C. Lahn, M. Hammett, T. van der Veen, L. Johnson, Z. Pickering, C. Santoro, A. |
| author_facet | Carlostella, C. Lahn, M. Hammett, T. van der Veen, L. Johnson, Z. Pickering, C. Santoro, A. |
| author_sort | Carlostella, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429685 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94296852022-08-31 P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) Carlostella, C. Lahn, M. Hammett, T. van der Veen, L. Johnson, Z. Pickering, C. Santoro, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429685/ http://dx.doi.org/10.1097/01.HS9.0000847332.17703.45 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Carlostella, C. Lahn, M. Hammett, T. van der Veen, L. Johnson, Z. Pickering, C. Santoro, A. P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) |
| title | P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) |
| title_full | P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) |
| title_fullStr | P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) |
| title_full_unstemmed | P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) |
| title_short | P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) |
| title_sort | p1116: safety, pharmacokinetic (pk), pharmacodynamic (pd) and activity of the highly selective phosphoinositide 3-kinase inhibitor delta (pi3kδ) inhibitor ioa-244 in patients with follicular lymphoma (fl) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429685/ http://dx.doi.org/10.1097/01.HS9.0000847332.17703.45 |
| work_keys_str_mv | AT carlostellac p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl AT lahnm p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl AT hammettt p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl AT vanderveenl p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl AT johnsonz p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl AT pickeringc p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl AT santoroa p1116safetypharmacokineticpkpharmacodynamicpdandactivityofthehighlyselectivephosphoinositide3kinaseinhibitordeltapi3kdinhibitorioa244inpatientswithfollicularlymphomafl |